Literature DB >> 7092449

Thyrotoxic periodic paralysis with ventricular fibrillation.

J Fisher.   

Abstract

Electrocardiographic conduction disturbances and nonspecific interval changes are not uncommon during hypokalemic periodic paralysis. Although premature ventricular contractions may occur during the paretic episodes associated with hyperkalemic, normokalemic, and hypokalemic periodic paralysis, ventricular tachycardia is rare; to my knowledge, ventricular fibrillation has not been previously reported. In 1977 a 40-year-old man of Puerto Rican descent was resuscitated from ventricular fibrillation and subsequently received a diagnosis of thyrotoxic hypokalemic periodic paralysis. Following thyroid suppression the patient has been asymptomatic; ambulatory ECG monitor, maximal exercise stress test, and echocardiograms have been normal. This case documents the occurrence of ventricular fibrillation in thyrotoxic periodic paralysis.

Entities:  

Mesh:

Year:  1982        PMID: 7092449

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  Familial "hashitoxic' periodic paralysis.

Authors:  A K Leung
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

2.  Amiodarone-induced destructive thyroiditis associated with coronary artery vasospasm and recurrent ventricular fibrillation.

Authors:  Matthew J Brooks; David A Pattison; Eliza P Teo; Sarah Price; Ronen Gurvitch
Journal:  Eur Thyroid J       Date:  2012-11-30

Review 3.  Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.

Authors:  Rui M B Maciel; Susan C Lindsey; Magnus R Dias da Silva
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

4.  Thyrotoxic hypokalemic periodic paralysis in a Turkish male with graves' disease: a rare case report and review of the literature.

Authors:  Cihangir Erem
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

Review 5.  Arrhythmia and thyroid dysfunction.

Authors:  S Marrakchi; F Kanoun; S Idriss; I Kammoun; S Kachboura
Journal:  Herz       Date:  2014-07-04       Impact factor: 1.443

6.  Population-based studies of antithyroid drugs and sudden cardiac death.

Authors:  Charlotte van Noord; Miriam C J M Sturkenboom; Sabine M J M Straus; Albert Hofman; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

7.  Unusual Manifestation of Graves' Disease: Ventricular Fibrillation.

Authors:  Hiroki Kobayashi; Akira Haketa; Masanori Abe; Kazunobu Tahira; Yoshinari Hatanaka; Sho Tanaka; Takahiro Ueno; Masayoshi Soma
Journal:  Eur Thyroid J       Date:  2015-08-26

Review 8.  Thyrotoxic periodic paralysis: an overview.

Authors:  Chang-Hsun Hsieh; Shi-Wen Kuo; Dee Pei; Yi-Jen Hung; Sandra Chyi-Fan; Ling-I Wu; Chih-Tsueng He; Tsao-Chin Yang; Wei-Cheng Lian; Lee Chien-Hsing
Journal:  Ann Saudi Med       Date:  2004 Nov-Dec       Impact factor: 1.526

9.  The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval.

Authors:  Ye Seung Lee; Joong Wan Choi; Eun Ju Bae; Won Il Park; Hong Jin Lee; Phil Soo Oh
Journal:  Korean J Pediatr       Date:  2015-07-22

10.  A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants.

Authors:  Chin-Chun Chang; Chih-Jen Cheng; Chih-Chien Sung; Tzong-Shi Chiueh; Chien-Hsing Lee; Tom Chau; Shih-Hua Lin
Journal:  Eur J Endocrinol       Date:  2013-10-01       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.